Add BrightSurf on Google Email

Science News for January 18, 2026


Brewing a rare medicine: Yeast engineered to produce a valuable astragalus isoflavonoid

Researchers have created a yeast platform capable of producing calycosin-7-glucoside, a valuable isoflavonoid from Astragalus membranaceus. The optimized strain achieved a titer of 0.22 mg/L within 48 hours, providing a scalable alternative to plant-derived production and reducing dependence on medicinal plant cultivation.

SourceNanjing Agricultural University The Academy of Science·JournalBioDesign Research·TypeExperimental study·DateJan 18, 2026

Memory justifications remain reliable over time, BGU study finds

A new study published in Communications Psychology found that verbal justifications supporting memories remain rich, detailed, and consistent even after a delay of 24 hours. The study suggests that memory justifications provide a temporally stable window into episodic memory, making them a reliable basis for evaluating memory credibility.

SourceBen-Gurion University of the Negev·JournalCommunications Psychology·TypeExperimental study·DateJan 18, 2026

Universal plasma wave phenomena revealed: Mercury’s BepiColombo Mio and Earth’s GEOTAIL show shared wave frequency properties across planetary magnetospheres

Researchers from Kanazawa University and partners have discovered chorus emissions in Mercury's magnetosphere, exhibiting similar chirping frequency changes to Earth's magnetosphere. This breakthrough provides the first reliable evidence of intense electron activity at Mercury, expanding our knowledge of planetary space environments.

SourceKanazawa University·JournalNature Communications·DateJan 18, 2026

Engineering yeast to make rare anticancer saponins: Reconstructing the complete biosynthesis of polyphyllin II

Scientists reconstructed the complete biosynthesis of polyphyllin II in yeast using plant transcriptomics and enzyme engineering. The study demonstrated the full heterologous production of polyphyllin II, enabling a sustainable alternative for producing complex medicinals.

SourceNanjing Agricultural University The Academy of Science·JournalBioDesign Research·TypeExperimental study·DateJan 18, 2026

Engineered yeast delivers record levels of animal-free chondroitin sulfate

Researchers achieve high product yield and sulfation quality in engineered yeast, enabling sustainable production of high-quality chondroitin sulfate without animal sources. The optimized strain delivers 7.13 g/L CSA with a stable sulfation degree of 48.4%, promising cleaner and more sustainable products.

SourceNanjing Agricultural University The Academy of Science·JournalBioDesign Research·TypeExperimental study·DateJan 18, 2026

Hierarchically converged defect engineering with 2-dimensional black phosphorus/MXene sequence for sensitive photoelectrochemical-electrostatic sensors

Researchers propose a hierarchically converged defect-engineering strategy to construct a multidimensional ZnO/Bi₂O₃/BiOCl/BP/MXene heterojunction photoelectrode framework. This targets modulation increases the electrochemically active surface area, optimizes energy-level alignment, and establishes efficient carrier transport pathways.

SourceResearch·JournalResearch·TypeNews article·DateJan 18, 2026

Pioneering second-order nonlinear vibrational nanoscopy for interfacial molecular systems beyond the diffraction limit

Researchers overcome spatial resolution limit of sum-frequency generation (SFG) spectroscopy by utilizing plasmonic near-field confinement. This breakthrough enables direct visualization of nanoscale orientation heterogeneity in interfacial molecular domains.

SourceNational Institutes of Natural Sciences·JournalThe Journal of Physical Chemistry C·TypeExperimental study·DateJan 18, 2026

No clear evidence that cannabis-based medicines relieve chronic nerve pain

An updated Cochrane review of 21 clinical trials involving over 2,100 adults found no high-quality evidence that cannabis-based medicines reduce neuropathic pain more than placebo. Small improvements were reported by patients using products with both THC and CBD, but these changes were not clinically meaningful.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateJan 18, 2026